Whilst declawing is illegal in many countries of the world, it remains surprisingly common in others, including North America, where it is performed electively to stop cats from damaging furniture, or as a means of avoiding scratches.
The operation to declaw does not just remove the claw, but also the end bone of the toe. Previous research has focused on short-term issues following surgery, such as lameness, chewing of toes and infection, but the long-term health effects of this procedure have not to date been investigated.
For the study, the author group, based in North America, investigated a total of 137 non-declawed cats and 137 declawed cats, of which 33 were declawed on all four feet. All 274 cats were physically examined for signs of pain and barbering (excessive licking or chewing of fur) and their medical history was reviewed for unwanted behaviours.
They found that inappropriate toileting, biting, aggression and over-grooming occurred significantly more often in the declawed cats than the non-declawed cats (roughly 7, 4, 3 and 3 times more often, respectively, based on the calculated odds ratio).
A declawed cat was also almost 3 times more likely to be diagnosed with back pain than a non-declawed cat (potentially due to shortening of the declawed limb and altered gait, and/or chronic pain at the site of the surgery causing compensatory weight shift to the pelvic limbs).
International Cat Care has issued a position statement saying that even if surgical techniques were improved to negate some of the adverse effects of declawing, it would remain of the opinion that the procedure is unethical other than if required to manage a medical condition, and should be legislated against wherever possible.
Reference
The £35 course is aimed at veterinary surgeons, veterinary nurses, receptionists and practice managers who may be faced with difficult and sensitive conversations around pet loss with clients. It covers:
Empathy vs sympathy
Communicating with active listening skills
Open questions
Face-to-face emotional support, telephone support, email support and other written communication
The Blue Cross says that the new course complements its £280, eight-week 'Pet Bereavement Support' course for more in-depth training, and also its hourly webinars, which cost £20.
The eight-week course requires a minimum of three to four hours of study per week and counts towards 32 hours Continual Professional Development.
For specific needs, the Blue Cross can also work with practices to provide bespoke face-to-face training across the UK, specifically tailored and delivered at the practice.
For more information, visit www.bluecross.org.uk/pbss-course or call 01993 867216.
The first MRCVS to be killed in the First World War has been honoured with a portrait at the College's offices in Belgravia House - 100 years after his death.
The portrait of Lieutenant Vincent Fox, who was from Dundalk, Co Louth, and was an alumnus of the then Royal Veterinary College in Dublin, was presented by his great grand-nephew, James Tierney, and received by RCVS Registrar Gordon Hockey.
Lieutenant Fox, a member of the former Army Veterinary Corps (AVC), was killed in action by a shell on August 26 1914 during the Battle of Le Cateau in northern France in which British and French forces fought to impede a German advance. He is now buried in the nearby Commonwealth War Grave Cemetery at Caudry.
Paul Watkins, a veterinary surgeon and military historian, conducted the research into Lieutenant Fox, his career and his deeds in the First World War, with the help of his family. He said: "The family story was that he had been found dead in a church with no mark or scars on him and, in fact, this turned out to be completely true.
"The church where he died was in the village of Audencourt in northern France where a dressing station had been set up for the wounded.
"The key issue was that, in the absence of the Royal Army Medical Corps, Lieutenant Fox was ordered to take charge of the medical treatment of the men using his skills as a veterinary surgeon. I'm sure he did his very best under such extreme circumstances but he would have been very ill-equipped."
Talking more generally about the role of the AVC during the First World War, Dr Watkins said: "The AVC made very significant contributions to the war effort because there were so many horses and mules deployed. They would have been responsible for a range of tasks from husbandry - and educating other soldiers on husbandry - to the treatment of injured animals."
In total, some 67 veterinary surgeons are believed to have been killed in the First World War - of whom 34 died from disease, 24 died as a result of wounds and nine were killed in action.
On presenting the portrait, which was drawn by artist Dave Gleeson based on a photograph of Lieutenant Fox, Mr Tierney, from Dublin, said: "I am very pleased that the Royal College of Veterinary Surgeons has accepted this portrait as future generations of vets will be able to see it here and learn about my great grand-uncle's story.
"He has become my hero because he died while trying to save human lives and, for me, that's a huge source of pride.
"While his story is very interesting, however, it's not just about him. There are 66 other names on the RCVS First World War memorial and they all have a story to tell as well."
Gordon Hockey, RCVS Registrar, added: "We are very pleased to receive this portrait of Lieutenant Fox in recognition of the sacrifice he made during the First World War. The fact that he died while tending to his wounded fellow soldiers demonstrates the caring nature of the profession and the wider contribution to society made by veterinary surgeons.
"In this centenary year I would also like to commend the contribution made by members of the profession as a whole during the war."
Throughout the centenary the RCVS Knowledge Library blog - written by Clare Boulton, Head of Library and Information Services - will be updated with stories about the conduct of veterinary surgeons in the First World War. Visit rcvsknowledgelibraryblog.org to see the updates.
The British Veterinary Association (BVA) has welcomed the Kennel Club's confirmation that, from January 2010, all dog owners and breeders wishing to participate in the Kennel Club/BVA Canine Health Schemes (CHS) for eye disease and hip and elbow dysplasia will be required to have their dogs permanently identified with either a microchip or tattoo.
BVA President Nicky Paull said: "This move has been introduced at the express wish of the veterinary profession through the BVA and we are delighted that the Kennel Club has taken our view on board.
"In November, following discussion at our Ethics & Welfare Group, we called, along with an independent review of the breeding of dogs, for the permanent identification of all registered pedigree dogs. The inclusion of this requirement for participation in the Canine Health Schemes is hopefully the first step."
Vet practices across the UK are being urged to get involved with Pet Smile Month to increase practice footfall and attract new clients in the tough economic climate.
Pet Smile Month, which runs during September 2009, is the world's largest veterinary-led pet health campaign and requires practices to offer a free dental check to pets by appointment during the month. The initiative aims to improve understanding of the importance of dental disease in dogs, cats and other pets and to encourage better dental care.
Over 1,500 UK practices have supported the campaign in recent years and some have reported increases of up to 10% in dental treatments in the months following the campaign. High profile sponsors; Pedigree, Whiskas, Petosan, Genitrix and Logic are supporting this year's Pet Smile Month.
There is no cost for participating and those practices which do will receive supplies of goody bags containing samples of Pedigree® DentaStixTM or Whiskas® DentaBitsTM, together with information leaflets, competitions and other special offers, to give to clients with their free dental health check.
Bob Partridge, the organiser of Pet Smile Month, is working with the sponsors on a major local radio publicity campaign at the end of August to raise awareness of Pet Smile Month and encourage pet owners to contact their local participating practice. The deadline to sign up is Monday 17 August 2009. Full details of how to get involved are available at www.petsmile.org or by calling 08714 24 25 26.
Time is running out to nominate your fellow staff members for this year's 'Petplan Pet Insurance Advisor Award'.
The award recognises the hard work and dedication that Pet Insurance Advisors (PIAs) do to highlight the importance of insurance to pet owners so that they are protected financially.
Donna Lewis, President of The British Veterinary Nursing Association said: "The PIA in a practice is an important role for a member of staff to fill and the award is just as relevant as the Vet Nurse of the Year or Receptionist of the Year award. The Petplan PIA Award recognises the individual who fully understands and works to help educate clients and staff about insurance, it is also recognises their passion for their role."
To nominate your dedicated PIA for Petplan's PIA of the Year Awards, please visit www.petplan.co.uk/pia. The PIA of the Year will receive a new laptop and their practice will receive £100 in vouchers!
Nominations close on 3rd September and the nominees will be judged by industry professionals. The winner will be announced at the annual BVNA Congress on 9th October.
The University of Bristol's Langford Veterinary Services (LVS) has announced the completion of its new clinical facilities.
The first phase of the £13 million development includes a new small animal surgery building, comprising five theatres, an ICU, a dedicated anaesthesia induction and recovery and an imaging suite.
The imaging suite comprises a 16-slice CT scanner, for small animals and horses, conventional digital radiography with a DR system, a high-resolution fluoroscopy, diagnostic ultrasound, echocardiography, scintigraphy and a high resolution 1.5 tesla MRI scanner available seven days a week.
Lynne Hill, Chief Executive of LVS, said: "The new facility provides state-of-the art diagnostic imaging facilities at all times, to help the animals under our care."
LVS highlights the case of Gainsborough, an eight-year-old Irish draught gelding, to illustrate the benefits of its new facilities. The horse, used for jumping and endurance, was initially presented to the Equine Hospital in October 2010, with clinical signs including nasal airflow obstruction and discharge, which was limiting his athletic capabilities.
Using videoendoscopy and radiography, a space-occupying mass was diagnosed in the paranasal sinuses impinging into the nasal cavity. With the horse conscious, but sedated, using regional local anaesthetic nerve blocks, the bulk of the mass was removed and he returned to work. However, the owner reported a recurrence of the clinical signs and he was returned to the clinic for reassessment.
The new imaging suite, only one of a few such units in the UK, has been adapted to enable the imaging of a horse's head while conscious using a frictionless air plinth. The adaptation allows detailed imaging of both bone and soft tissue structures within a horse's head, without requiring a general anaesthetic.
Using the new imaging suite, Gainsborough's CT examination revealed a portion of the mass, which had been inaccessible to the previous keyhole surgery, had expanded into the nasal cavity. The detail of the images enabled careful planning of a second operation that facilitated removal of the large remnant of the mass, which appeared to be benign, with minimal collateral trauma.
In addition to imaging the heads of conscious horses, dogs and cats are able to undergo complete body scans using the same unit while anaesthetised. As well as enabling detection and diagnosis of lesions without invasive or painful tests at an earlier stage, the unit will facilitate operative planning and add to the body of knowledge of disease pathogenesis.
For more information about LVS, visit: http://www.langfordvets.co.uk/
Participants travel around South Africa working on game reserves, commercial farms and in poor communities, getting experience of game capture, providing veterinary care in townships and rural areas, working in a private clinic and handling and treating large farm animals.
There are also a range of weekend activities, including kayaking, quad biking, game drives, horse riding, surfing, beach walking, bars and restaurants.
Kim said: “We’ve designed the programme so that it’s suitable for people with a wide range of experience, including veterinary and veterinary nursing students, young people considering a career in the veterinary profession and animal lovers.”
For more information, visit: wildinsideadventures.com
The study1, which was conducted in collaboration with Plymouth University, sought to find out what influences owners to buy a flat-faced breed, and once this decision has been made, how they go about acquiring a puppy. The study surveyed owners of the top 10 most popular Kennel Club registered breeds in the UK, to compare how influences upon breed choice and purchasing processes differed between owners of flat-faced breeds and popular longer-faced breeds.
Appearance was found to be the number one reason owners purchase flat-faced breeds, attracted by their large, round, wide-set eyes, and flat rounded faces. However, such characteristics are linked with lifelong respiratory, eye and skin problems, and a reduced lifespan compared with longer-faced breeds.
Key influencing factors associated with the choice of a brachycephalic breed included:
When it came to buying a flat-faced dog, owners were:
Dr Rowena Packer, lead author of the study and Research Fellow at RVC, said: "With their small size and baby-like features, some people cannot resist the looks of a brachycephalic dog. With growing evidence that these breeds are faced with a range of chronic and severe health conditions directly linked with their appearance, it is of huge concern that many people drawn to these breeds prioritise a dog’s looks over their long-term health and wellbeing.
"Potential puppy buyers attracted to the appearance of these breeds should seriously consider whether they are emotionally and financially prepared to take on a breed with high risks of health complications, and consider whether alternative, lower-risk breeds would better fit their lifestyle."
Co-author of the study and Associate Professor of Animal Welfare at Plymouth University, Dr Mark Farnworth, said: "Owners must be aware that as puppy-buyers, they are consumers, and their choices affect not only the health of the puppy they purchase, but also the health of the breed more widely. If owners do not follow recommended processes when purchasing a puppy, for example those set out in BVA AWF & RSPCA ‘Puppy Contract’, unscrupulous breeders will be kept in business, and continue to profit from the breeding and sale of unhealthy dogs. Without consumer awareness, breed health improvements are not possible and the overall health of these breeds will likely decline."
Paula Boyden, Dogs Trust Veterinary Director said: "The increased popularity of breeds such as Pugs, French Bulldogs and English Bulldogs is a huge welfare concern, particularly as this research indicates that the health of the breed was not a major consideration for potential puppy buyers. Many people mistakenly believe that the breathing sounds these breeds often make are endearing traits, rather than an indication of respiratory problems associated with their conformation. Dogs Trust urges anyone thinking of getting a puppy to look beyond the appearance of a breed, understand the impact on health, research the seller and buy responsibly."
Researchers say that the French Bulldog is set to become the most registered dog in 2017, overtaking the Labrador Retrievers’ 27-year reign at the top. The study therefore makes a number of recommendations, including:
Photo: Wikipedia CC BY-SA 3.0 Credit: Cristorresfer
Bayer Animal Health, maker of Advocate, says that since February, veterinary surgeons have reported more than 80 cases of canine lungworm infection in the UK, of which six have died.
The fatal cases were reported in Salisbury, Crawley, Ipswitch and Essex.
Of the 84 cases reported, 43 practices said it wasn't their first. With no requirement for compulsory reporting, Bayer says it is likely that other cases have gone undocumented.
Although the majority of cases reported to Bayer were found in the South of the UK, others were reported as far north as Paisley in Scotland. This, says the company, adds to the increasing base of evidence that lungworm is endemic throughout much of the UK and continues to pose a significant threat to dogs.
Recent research by Bayer found that 37% of veterinary surgeons thought cases of lungworm had increased in their area over the last five years.2
The company also points towards a study from the University of Bristol which examined the fox population and found further evidence of the parasite's spread across the UK.3 The research suggests that the overall prevalence of A.vasorum in foxes is 18.3% in the UK, significantly higher than a previous study published in 2008, which reported a prevalence of 7.3%.3
The South East is reported to have the highest prevalence, with 50% of foxes now found to be infected (more than double the previous figure). In the North of England and Scotland, 7.4% of foxes were found to be infected despite none being found in this region in the earlier study.
Dogs which have picked up a lungworm infection can show a number of different symptoms including breathing difficulties, a lack of energy, coughing and persistent bleeding. However, the clinical signs can be varied and some dogs may appear healthy in the early stages of infection.
Gavin McAulay, a cardiorespiratory specialist at New Priory Veterinary Hospital in Brighton said: "With often confusing symptoms, the clinical judgement of vets is key in ensuring an animal is diagnosed and treated against lungworm as soon as possible. In many scenarios lungworm should be a consideration to be assessed in the background whilst investigating other conditions, however monthly prevention is key. There is evidence with other parasite diseases that suggests the more animals you treat, the better protected other animals in the area are."
Bayer’s 'Act Against Lungworm' campaign is urging veterinary surgeons to encourage monthly lungworm preventative treatment. Prevention which stops larval shedding will also help limit the geographical spread of the disease.
Donna Tomlinson, Senior Product Manager for Advocate said: “With the continued spread of lungworm in the UK, it is important to ensure that our 2017 ‘Act Against Lungworm’ campaign resonates with local communities. We have the case studies to show that lungworm has been reported across the UK, but we rely on the support of vets to help get the message out.
"This year we are putting local vets at the center of our communications, with dedicated campaigns planned in every region. This is a great opportunity for practices to get involved in a local media campaign, talk about their first-hand experiences with the parasite and encourage pet owners to visit them for advice on preventative treatment.”
Veterinary surgeons can report cases to their local Bayer Territory Manager or practices can log their own incidences directly by emailing lungworm@bayer.com.
'Act Against Lungworm' veterinary campaign materials are available for practices to display in waiting rooms, as well as leaflets to assist practitioners in communicating to dog owners the importance of protecting their pet against lungworm. These can be ordered at the Bayer Vet Centre (www.vetcentre.bayer.co.uk).
References:
Vets Now has reached the final of the "Employer of the Year" at the forthcoming Private Business Awards.
Judged by a panel of key UK business leaders, the winners will be announced at an awards ceremony on 6th September 2012.
More than 600 businesses throughout the UK entered the awards. Richard Dixon, founder of Vets Now said: "We are delighted to have reached the final in the Employer of the Year category. We have an absolutely amazing bunch of vets, nurses and receptionists across the country and I am hugely proud of them. They work their socks off; frequently in really challenging circumstances and have significantly contributed to improving the quality of life for the profession and the quality of Out of Hours care available for pets.
"Caring for animals is at the heart of what we do and we treat over 100,000 pets every year through our network of 53 emergency clinics. The very nature of Out Of Hours emergency veterinary care is very challenging to the profession and the support we offer to veterinary practices is also extremely important to us. In the last year our services have enabled more than 2,000 vets up and down the country to have their nights and weekends off, while their clients receive a high quality Out of Hours service. Our referral services also ensure that pets needing care from recognised Specialists can receive this from a trusted team."
The Easy to Give Awards are given to pharmaceutical companies that have made it easier to give medication to cats:
Dechra for Felimazole coated tablets for cats
Zoetis for Stronghold Plus spot-on solution for cats
Zoetis for VibraVet Paste
Bayer for Seresto flea and tick collar for cats
The Cat Friendly Awards recognise products which have made a difference to cat wellbeing:
ProtectaPet for cat fencing solutions
Coastline Global for Kit4Cat Cat Urine Sample Collection Sand
Sure Petcare for its SureFlap Microchip Pet Door Connect with Hub
The Distance Education Awards recognise the best students on the International Society of Feline Medicine’s Vet Nursing courses
Sarah Hayward and Rachael Hodgeson for best results achieved in the Certificate in Feline Nursing
Margaret Hodgeson for the best result received in the Diploma in Feline Nursing
In addition, International Cat Care made a special award in 2018 for products and ideas which have made major contributions to the ability to help cats in the field of Trap, Neuter, Return (TNR). The Innovation in Humane Cat Population Management Award was given to MDC Exports for its traps, restrainers and transfer baskets.
Lastly, the winner of the 2018 iCatCare Photography Competition winner, awarded to the overall winner of the charity’s ‘Kittenhood’ photo competition, was Lindsey Chadwick.
Photo: Sarah Hayward receiving her award from Erin Biss of Royal Canin (right) and iCatCare Chairman Stuart Carmichael (left)
Prilactone®, the world's first aldosterone antagonist licensed for the treatment of canine heart disease, has been introduced by CEVA Animal Health.
Clinical trials have demonstrated that the product, which contains spironolactone, can improve quality of life and help to reduce the mortality risk in canine heart disease patients.
Fraser Broadfoot BVetMed GPCert(SAP) MRCVS explains "Spironolactone is considered as part of standard disease therapy in humans, where studies have demonstrated a 30% reduction in the risk of mortality when it is used in addition to ACE inhibitors and furosemide. The results of clinical trials performed by CEVA Santé Animale have demonstrated even more dramatic benefits in the dog. In short, the trials show that dogs with heart failure receiving Prilactone®, in combination with an ACE inhbitor and furosemide, demonstrated a 65% reduction in the risk of mortality compared with dogs receiving a placebo. Their quality of life was also improved." The beef-flavoured tablets are scored for easy breaking and come in three sizes for the precise dosing of all sizes of dog. In addition, the medication only needs to be given once daily with food and is designed to be given alongside standard first-line therapy for heart disease.
For further information about Prilactone®, please contact CEVA Animal Health on (01494) 781510.
Note 1 CEVA registration dossier. The trials were carried out on 221 dogs diagnosed with heart disease. The animals treated with Prilactone®, in conjunction with ACE inhibitors and /or furosemide over a period of 14-15 months, demonstrated a three times reduction in the risk of death compared with the placebo group. Note 2 Wood Mackenzie, Cardiovascular Insight, July 2007
The Mercury Challenge, which is being conducted by Ceva Animal Health, aims to collect data on 10,000 cats across Europe to provide a new insight into the detection and management of feline hypertension, a frequent and severe condition that is still not routinely checked1.
Vet nurses participating in the initiative need to input five mandatory pieces of information at mercurychallenge.ceva.com: the owner’s name, cat’s name, age, systolic blood pressure and time spent measuring blood pressure. Additional information includes: weight, breed, sex and whether the animal has any concurrent diseases, such as chronic kidney disease or hyperthyroidism, or is on any treatments.
Participating practices will be given exclusive access to the study’s progression and results, as well as acknowledgements for their contribution to the Mercury Challenge, depending on the number of cats entered.
Imane Mahlous, cardiology-nephrology and hypertension product manager at Ceva Animal Health said: "It is quick and easy to take part in the Mercury Challenge, which we hope will revolutionise the way that feline hypertension is understood and treated by both cat owners and veterinary professionals."
For information on feline hypertension or the Mercury Challenge, contact your local Ceva Animal Health account manager or visit mercurychallenge.ceva.com.
The British Association of Veterinary Emergency and Critical Care (BAVECC) is carrying out a survey of the veterinary profession about 24/7 emergency veterinary cover, the results of which will be presented to the RCVS Standards Committee during its forthcoming review.
Toby Birch MRCVS from BAVECC said: "We are aware that there has been much debate on the subject however we feel that much of what has been aired is subjective opinion. While we appreciate that this is very valuable, BAVECC would like to try and place some objectivity on this matter."
If you're working in small animal practice in the UK, please take part in the survey here: https://www.surveymonkey.com/s/JYKNC5J.
The results will be shared with members of VetSurgeon.org and VetNurse.co.uk in due course.
According to the survey, 64% of veterinary surgeons now see Brexit as more of a threat than an opportunity for the UK veterinary profession, compared to just half in autumn 2016. Conversely, the number that see Brexit as being more of an opportunity has dropped from 18% to 14% over the same period.
Vets working in academia and industry were the most gloomy: 69% of vets in academia and 58% of vets in industry see Brexit as more of a threat to their own area of work than an opportunity.
The biggest impact appears to have been on veterinary recruitment, with 53% saying Brexit has made it harder to recruit veterinary surgeons, compared to only 18% in 2016. By comparison, only 11% said it has become harder to recruit veterinary nurses.
51% also now consider Brexit as a threat to animal welfare, compared to 43% in 2016.
BVA President Simon Doherty (pictured right, looking decidedly chipper despite it all) said: "As the UK Government ramps up its planning for a no-deal scenario, it’s clear that the veterinary profession is becoming increasingly concerned about the potential impact of Brexit.
"Top of vets’ list of concerns is significant veterinary workforce shortages across critical areas of animal welfare and public health. Veterinary concerns around animal welfare have also increased as the Government continues to stall on introducing new legislation to enshrine animal sentience in UK law before March.
"From pet passports and food safety, to disease surveillance and trade certification, there is no area of veterinary work that is not touched by Brexit. So, we can fully understand why our members are worried about the future. BVA will continue to raise these important veterinary issues with policymakers to ensure the profession is considered as Brexit discussions continue."
The BVA briefings on “Brexit and the veterinary profession” and “No deal Brexit and the veterinary profession” set out all of the issues of interest in more detail.
The National Office of Animal Health (NOAH) and the International Federation for Animal Health Europe (IFAH) have welcomed the European Commission's publication of proposals for revised legislation concerning veterinary medicines and medicated feed earlier today.
The EC says the proposals are designed to increase the availability of veterinary medicines, reduce administrative burden, stimulate competitiveness and innovation, improve the functioning of the internal market and address the issue of antimicrobial resistance.
NOAH says that currently, the manufacturers of veterinary medicines struggle with a regulatory system with some serious flaws, including:
NOAH chief executive Phil Sketchley said: "NOAH will be looking at the detail of the texts in the coming days and weeks, and reviewing their potential impact. We look forward to working with the VMD, who have called stakeholder workshops to examine the texts. We will also be supporting our European federation IFAH-Europe as they work determinedly with the European institutions over the coming years to support the Commission's vision for a more efficient regulatory system for veterinary medicines in Europe.
"We believe the value our industry brings to society is very high, despite being quite a small sector. For example, veterinary medicines benefit public health by preventing zoonotic disease and supporting food security.
"With synergies with our own UK Government's commitment to reduce unnecessary red tape, which is a key theme for DEFRA, the animal health industry in Europe needs greater efficiency to cut the red tape for our industry. We look forward to a streamlined registration process which delivers a single European marketing authorisation for all veterinary medicines.
"We will also be considering if the text has any particular implications for the UK animal health market and access to medicines for our animals."
NOAH says it also welcomes the revised medicated feed legislation. Phil Sketchley said: "NOAH believes this is an important route for administering prescription medicines to animals. We will work to help ensure the legislation is capable of maintaining and strengthening this route."
Ben trained in medicine at Oxford and London before becoming a household name through his weekly Bad Science column published in the Guardian between 2003 and 2011.
Ben is the author of three books. His first, Bad Science, published in 2008, sold over half a million copies worldwide and is published in 31 languages. His second, Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients was published in 2012 and his third, a volume of collected journalism entitled I think you’ll find it’s more complicated than that, in 2014. He currently works as an academic in epidemiology.
In his lecture, Ben will be talking about how quacks and charlatans misuse evidence, and the placebo effect, to bamboozle the public. It's an issue of particular interest for the veterinary profession, given the growing focus on evidence-based medicine.
The lecture is open to all London Vet Show attendees and will take place in the BVA Congress Theatre at London’s ExCeL between 12.30 – 1.30 on Friday 17 November.
BVA President Gudrun Ravetz said: "We know that many people’s first point of call is the media or Dr Google when trying to decide what pet to purchase or how to treat their animal’s - or their own - health! So, I’m sure veterinary colleagues from all areas of the profession will find Dr Goldacre’s insight both engaging and inspiring in their day-to-day and working lives."
Other BVA Congress sessions at London Vet Show 2017 include Nudge, nudge – how can we change owner behaviour for better welfare?; Veterinary workforce crisis: what’s really going on? and Veterinary Surgeons Act: an open and shut case?. BVA Congress sessions as well as associated BVA Farm Animal, BVA/BEVA Equine, and BVA Career Development Streams count towards CPD.
BVA members can get access to the full BVA offering, as well as the usual London Vet Show programme, for 15% less than the lowest advertised price. To book, enter your BVA membership number and the code BVA 8 to claim your discount when you book online at www.londonvetshow.co.uk
Photo: John King 2012
Bayer Animal Health has announced that it will launch Seresto, a new POM-V collar for cats and dogs that kills fleas and repels and kills ticks for up to eight months, in March.
According to Bayer, Seresto is the first treatment to provide repellency against ticks in both cats and dogs, and represents the fruit of a multidisciplinary effort incorporating the company's research into insecticides, polymers and veterinary parasiticides. The end result is a polymer-based collar that transfers the active ingredients to the lipid layer, from where they are spread by the animal's neutral oils.
Bayer Animal Health group product manager, Caroline Braidwood, said: "Seresto is simple to use on both cats and dogs. And because it is long lasting, it offers pet owners an alternative to those struggling to maintain a monthly routine. Bayer believes in innovation and Seresto is an enhancement to our product portfolio that meets the needs and requirements of pet owners and vets alike in the treatment of ticks and fleas."
Seresto contains two active ingredients - imidacloprid for fast action against fleas and flumethrin, which repels and kills ticks.
Caroline added: "Thanks to Seresto's unique polymer structure the active ingredients are safely locked away in the collar's matrix, and are released directly from the collar surface into the lipid layer of the animal at just the dose needed, ensuring optimal protection is sustained for up to 8 months."
Bayer says that because of its repellent (anti-feeding) effect, Seresto reduces the risk of vector-borne disease transmission - a first for cats. The company also says that because the active ingredients are stored on the inside of the polymer, it doesn't matter if the pet is shampooed and the lipid layer stripped off - the active ingredients are quickly replenished by the collar.
Seresto is odour-free and has a safety release mechanism to prevent strangulation. It is available in three sizes, Seresto Cat for cats less than 8kgs, Seresto Small Dog for dogs up to 8kgs and Seresto Large Dogs, for dogs over 8kg.
For further information about Seresto, contact your Bayer territory manager or call 01635 563000.
The Blue Cross is offering a lifeline to even more needy pets across the UK following an extension to its successful veterinary grant scheme.
Relaunched as "The Blue Cross Veterinary Care Fund", the charity has increased available funding and doubled the maximum grant it will pay towards veterinary costs of a particular treatment, operation or neutering procedure if the owner can't afford it.
The initiative was first launched in 2005 to help pet owners on low incomes who do not live near Blue Cross hospitals or clinics. So far the charity has awarded thousands of grants through 1,100 veterinary practices, 28% of all private vets in the UK. The demand from needy pets around the country prompted The Blue Cross to increase the maximum grant to £200 towards the veterinary treatment costs.
Pet owners must be on a means tested benefit or state pension with no other income to be eligible for support through the Veterinary Care Fund. Those on a very low income may also be eligible for the grant and should contact The Blue Cross for further advice.
The charity is also opening a new veterinary welfare clinic on 3 June 2008. The clinic, based at the animal adoption centre in Tiverton, will carry out basic procedures such as microchipping and vaccinations, and treat minor ailments. More serious or complicated cases will be referred to a local veterinary practice where treatment will be subsidised by The Blue Cross.
For more information about the Veterinary Care Fund or how clients can apply please contact The Blue Cross customer care team on 01993 825593 or email info@bluecross.org.uk
Fidavet has launched Surosolve, a vet wholesaler exclusive, non-prescription ear cleaner for cats and dogs.
Fidavet says the product has multiple uses for complete cat and dog ear cleaning:
Surosolve maintains healthy ears by acting as an antibacterial flush1, 2 and antibiotic potentiating agent2, 3 while contributing to restoring the normal microbiological balance of the ear canal.
According to the company, the product has already received positive feedback from veterinary practitioners that have used it: 79 per cent liked the appearance of the formulation and over 80 per cent appreciated the fragrance.
Helen Goldberg, marketing manager for Janssen Animal Health, said: "Surosolve has a unique, powerful yet non-irritant formulation, ideal for the ears of cats and dogs. This non-irritating solution with an almost neutral pH of 6.8 allows cleaning while respecting natural ear physiology.
"Surosolve also contains Tris-EDTA, which gives extra power to concurrent topical antibiotics. EDTA is a chelating agent, active in damaging the cell surfaces of bacteria, while Tris enhances the effect of EDTA by buffering the pH, ensuring the solution is not irritating to the ear and maximising the anti-bacterial effect."
Marion Lannegrace, Janssen Animal Health international product manager for Fidavet said: "The Fidavet range is only available through veterinary wholesalers because we firmly believe these products should be used only with veterinary advice. This gives clients peace of mind that their pet is receiving the best care."
For further information on Fidavet Surosolve, visit www.fidavet.com.
1 Cole LK. Anatomy and physiology of the canine ear. Veterinary Dermatology, 2010, 20 (5-6), 412-4212 Cole LK, Nuttall TJ. Pseudomonas otitis. Advances in Veterinary Dermatology, Proceedings of the Fifth World Congress of Veterinary Dermatology, 2005, (5), 324-3303 Roberts NA, Gray GW, Wilkinson SC. The bactericidal action of ethylenediaminetetraacetic acid on Pseudomonas aeruginosa. Microbios, 1970, (7-8), 189-208
Dr Sabela Atencia DVM MVM Dip-ECVIM CA MRCVS is an internal medicine specialist who holds the European Diploma in Small Animal Internal Medicine.
During her research for her Masters degree on muscular dystrophy in the Japanese Spitz breed, she contributed to knowledge of the underlying mutation of the disease, facilitating the development of a genetic test.
Sabela enjoys all aspects of canine and feline Internal Medicine, but is particularly interested in endoscopy, endocrinology and genetics.
Dr Owen Davies MA VetMB MVetMed MANZCVS(SAM) MRCVS, a veterinary medical oncology clinician, holds a Masters degree based on research into canine lymphoma.
Owen is interested in all aspects of medical oncology, especially haematopoietic malignancies, targeted therapy for cancer and paraneoplastic disease. He has recently completed a residency in veterinary oncology at the Royal Veterinary College and has just passed the DACVIM examinations in Oncology.
Dr Elisabetta Mancinelli DVM CertZooMed Dipl ECZM (Small Mammal) MRCVS is a European Veterinary Specialist in Zoological Medicine (Small Mammal Medicine and Surgery) and an RCVS Recognised Specialist in Zoo and Wildlife Medicine.
She was the first veterinary surgeon to undertake the European College of Zoological Medicine (ECZM) Residency in Small Mammal Medicine, which she completed at The Royal (Dick) School of Veterinary Studies, Edinburgh.
Elisabetta will lead and further expand the established exotic pet service at the Hospital.
Acting Hospital Director, Professor Stuart Carmichael said: "As we continue to extend the range of services and expertise we offer to our clients, we are delighted to welcome these three distinguished professionals to the team here at Highcroft. They will make a great contribution and it’s great to have them aboard."
Highcroft Veterinary Referrals is based at 615 Wells Road, Whitchurch, Bristol and can be contacted on 01275 832410.
Photo: Left to right: Dr Elisabetta Mancinelli, Dr Owen Davies, Dr Sabela Atencia
Mr Adams was convicted at Gorey District Court, County Wexford, Republic of Ireland in March 2015 for:
Nine offences of prescribing animal remedies to animals not under his care;
Five offences of forging entries in official animal remedies records owned by farmers to suggest he had made visits to farms when he had not;
Seven offences of dispensing a prescription-only animal remedy but not preparing a veterinary prescription containing the details of the animals;
Two offences of failing to affix labels in the required form to prescription-only items when selling or supplying animal remedies;
Six offences of failing to annotate the dispensed prescriptions with the word ‘dispensed’ and failing to sign and date them;
Three offences of failing to keep a record or purchases and sales (including quantities administered) in respect of each incoming and outgoing transaction; and
Two offences of selling animal remedies on a wholesale basis without an animal wholesaler’s licence.
The charges related to treatment of animals not under his care throughout 2012 and 2013 which were investigated by the Department of Agriculture, Food and Marine in the Republic of Ireland.
In relation to these convictions Mr Adams received a 12-month prison sentence, suspended for two years, was fined a total of €40,000 and ordered to pay costs of €16,400.
Following his conviction his conduct was considered by the Veterinary Council of Ireland’s (VCI) Fitness to Practice Committee and, in September 2017, the VCI a sanction of 12 months’ suspension from its Register. This sanction was upheld by the High Court in the Republic of Ireland in November 2017.
As well as being a registered veterinary surgeon in the Republic of Ireland, Mr Adams was also on the UK-practising Register with the RCVS, so his convictions were considered under the College’s own complaints and disciplinary process.
At the outset of the hearing, Mr Adams admitted the charges and accepted his convictions rendered him unfit to practise. The College also asserted that Mr Adams' convictions rendered him unfit to practise, noting a number of aggravating factors including the risk of injury to animals, dishonesty, premeditation, financial gain and misconduct sustained and repeated over time.
In considering the College’s case and Mr Adams’ own admissions, the Disciplinary Committee agreed that his conduct rendered him unfit to practise veterinary surgery.
Professor Alistair Barr, chairing the Committee and speaking on its behalf, said: "The Committee found the conduct to be at the serious end of the spectrum for such misconduct, it being systematic, prolonged and illegal conduct relating to the supply of animal remedies which posed a significant risk to human and animal health.
"Accordingly, the Committee found that the convictions which led to these charges cumulatively render Mr Adams unfit to practise."
In considering the sanction, the Disciplinary Committee took into account a number of mitigating factors including that he had been practising since 1993 and had no previous disciplinary findings, had made open and frank admissions at all stages to the College and had practised between April 2013, when the matters first came to light, and February 2018, when he was suspended by the Veterinary Council of Ireland, without incident.
It also considered the conditions that were imposed upon Mr Adams by the VCI in terms of notification that he was intending to return to practice, auditing of his practice, his continuing professional development (CPD) and having to undertake personal and professional support programmes and arrangements for professional mentorship for one year after his return to practice.
In view of the sanctions already imposed by the court in Ireland, and his suspension by the VCI, the Disciplinary Committee decided that a period of two years’ suspension from the UK Register of Veterinary Surgeons was the appropriate sanction.
Professor Barr said: "Whilst Mr Adams would be able to practise in the Republic of Ireland before he was able to practise in the United Kingdom again, the Committee considered that the conditions attached to his supervision in Ireland meant that he would be subject to close supervision before he was allowed to practise again in the United Kingdom and that only a longer period of suspension would allow this to happen.
"The Committee therefore decided that only a suspension of two years would maintain public confidence in the profession and declare and uphold proper standards of conduct for the serious nature of these charges."
Mr Adams has 28 days from being informed about the Disciplinary Committee’s decision to make an appeal to the Privy Council.
Oliver Jackson, Managing Partner at Pets’n’Vets said: "We pride ourselves in investing heavily in the training and enhancing the abilities of our already highly qualified and capable staff. Our latest training programme has been developed in response to a demand from our RVNs for a programme of structured additional training designed to meet their specific needs to enhance and develop their clinical skills.
"The modular programme, which takes place at the award-winning Roundhouse Veterinary Hospital, will feature a line-up of presenters with specialist knowledge delivering a range of learning objectives for participants encompassing such topics as anaesthesia and consulting, will be developed further in future years following feedback from RVNs enrolled on the course."
Ceri Boyd, RVN at the Pets‘n’Vets Family with responsibility for co-ordinating the initiative, said: "There is a growing recognition within the veterinary profession for RVNs to participate in the elevation of the status of veterinary nursing and we want to play an active part in that by helping RVNs blossom and realise their full potential.
"This initiative will endow our RVNs with the confidence they require to progress their skillsets and the initial feedback has been encouraging, with our nurses welcoming this opportunity to enhance their roles and responsibilities, offering the prospect for an even more rewarding career as a consequence of a programme that is not readily available in other veterinary practices."
Lottie, an 11-month-old Labrador puppy was found to have a very loud heart murmur during a routine check before being spayed.
An ultrasound revealed that she had several congenital defects. The two major ones were a malformation of her tricuspid valve and a very large defect of the common atrium.
Lottie was referred to the RVC’s cardiothoracic department where she underwent further ultrasound and a CT scan. The team at the RVC, which is led by Dan Brockman, Professor of Small Animal Surgery, had already performed several cutting-edge surgeries, including a world-first treatment to save the life of a dog born with a malformed tricuspid valve.
Repair of the tricuspid valve has only been performed a handful of times and has not been done at the same time as repair of a common atrium.
Lottie’s owners decided to proceed with the operation, which was undertaken at the end of July. Lottie's heart was stopped for the procedure and her circulation maintained with a heart lung machine run by perfusionist Nigel Cross from Great Ormond Street Hospital.
Poppy Bristow, Fellow in Cardiothoracic Surgery at the RVC, said: "Altogether 10 people were involved in her operation and many more for her care before and after surgery, including veterinary specialists, veterinary nurses and veterinary specialists-in-training from surgery, cardiology, anaesthesia and emergency and critical care, as well as Lottie’s referring cardiologist and her local veterinary practice.
"Lottie’s heart was stopped for an hour and a half, with the whole operation taking four hours. Her malformed tricuspid valve was released by cutting its abnormal attachments and artificial chords using Gore-Tex material were placed. Her single atrium was then divided into two using a large patch of Gore-Tex. Lottie has made a good recovery so far and was walking around and eating from the day after her surgery. She was discharged back to her owners after six days and has continued to thrive at home."
Professor Brockman added: "In Lottie, we had a young energetic dog with such a serious and life-limiting heart condition, that we were desperate to try and help her. The repair was complex but incorporated a combination of surgical manoeuvres that we had done before. With careful pre-operative planning and using our previous experience, we were able to design and execute the surgical treatment. It is still ‘early days’ but the initial signs suggest that Lottie is going to enjoy an excellent quality of life, following this operation and, we all hope, a normal lifespan."